The Coalition for Epidemic Preparedness (CEPI) will invest up to $50 million over 10 years to help Senegal's Institut Pasteur manufacture vaccines for the Global South, it said on Thursday.
JOHANNESBURG —
"The facility will ensure regional outbreaks are not neglected by deploying the latest technology for the greatest need," said Amadou Alpha Sall, CEO of Institut Pasteur de Dakar, a non-profit foundation in Senegal's capital.
CEPI, a global initiative headquartered in Norway, is creating a network of vaccine manufacturers in developing countries to help boost capacity and reserves for future outbreaks and pandemics.
At the height of the COVID-19 pandemic, a number of African nations complained that they were not able to get sufficient vaccine doses from suppliers, sparking calls for the continent to develop its own network of vaccine makers.